Fierce Biotech: Oramed phase 2 insulin drug data ‘paint an exciting picture’ in rocky NASH landscape September 13, 2022 In the News
In-Pharma Technologies: Afrezza’s launch a boost for alternate insulin delivery R&D, says Oramed June 2, 2015 In the News